The paradoxical behavior of oocyte maturity in advanced age: MII loss and GV gain

The central thesis is the paradoxical behaviour of oocyte maturity in advanced age. As the ovary ages, the effectiveness of cells retrieved already mature at the MII stage declines: aneuploidy becomes more frequent, spindle abnormalities appear more often, and nuclear and cytoplasmic maturation fall out of step. At the same time, oocytes aspirated immature at the GV stage, when matured in culture, show in a number of observations a relatively rising contribution to the final outcome.

Gleicher discusses the physiological mechanisms of this phenomenon as working hypotheses rather than proven causal links. He considers that some GV oocytes may have been held back in development by features of the follicular environment and stimulation rather than by true immaturity, and that their subsequent in vitro maturation sometimes yields cells with better preserved genomic and cytoplasmic integrity than oocytes that have aged already in the MII state.

The speaker also stresses the limits of interpretation. The point is a shift in relative effectiveness, not a call to abandon MII oocytes; the conclusions concern above all the cohort of older, low-prognosis women, where the absolute number of oocytes is small and the value of each cell is high. The patterns are discussed at the level of a concept and observed trends, without extrapolating single figures to the whole population.

The practical meaning for the clinic lies in reconsidering the attitude toward immature oocytes. In older patients, routine discarding of GV and MI cells may mean losing potentially usable material, while in vitro maturation programmes and careful embryological handling of the immature part of the retrieval gain added value. The lecture raises the question of a possible paradigm shift in IVF for this group — from simply counting mature cells to a finer assessment of competence.

The take-home message is an invitation for the reproductive specialist and embryologist to treat the formal maturity criterion more critically and to factor in the age context when planning the protocol, the retrieval strategy and the laboratory handling of oocytes, so as not to miss chances for patients for whom every single cell is especially precious.